Background and Objectives: Cancer and its treatment
often negatively affect patients’ quality of life (QOL).
A study of QOL among persons with prostate cancer
may help healthcare professionals in making an
appropriate care plan for promoting patients’ QOL.
This research aimed to explore quality of life among
persons with prostate cancer and to compare their
QOL classified by age, educational level, staging of
disease, and treatments.
Methods: This cross-sectional descriptive design
recruited 127 participants from persons with prostate
cancer admitted at a university hospital between
January and June 2017. The research instrument used
was a set of questionnaires, which consisted of the
Demographic data questionnaire and the Functional
Assessment of Cancer Therapy-Prostate-Thai
questionnaire (FACT-P). Data were analyzed using
descriptive statistics and the Kruskal-Wallis test.
Results: The mean score of an overall QOL among
persons with prostate cancer was at a high level
(120.78±14.72). Based on the test, the participants
receiving chemotherapy had an overall significantly
different QOL from the participants treated with
other methods (p=.039) by accounted was at a
moderate level (100.33±19.22). Considering each
aspect, the mean scores of QOL in physical wellbeing
aspect and cancer specific aspect were at a
moderate level (17.67±4.04, 28.00±4.59, respectively).
Conclusion: The result of this study revealed that
the participants receiving chemotherapy had an
overall QOL less than the participants treated with other methods. This finding suggests healthcare
professionals should focus on care planning in order
to reduce symptoms in persons with prostate cancer
undergoing chemotherapy to improve the patients’
QOL.